Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy

Isabel Heidegger1, Andreas Pircher2, Renate Pichler1

  • 1Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.

Insights

Renal cell cancer (RCC) treatments face resistance from the tumor microenvironment (TME). Understanding and targeting TME components can improve anti-angiogenic and immunotherapy effectiveness in RCC.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Renal cell cancer (RCC) is a vascularized and immunogenic malignancy.
  • Anti-angiogenic and immunotherapies have transformed RCC treatment.
  • Therapy resistance is a significant challenge, often driven by the tumor microenvironment (TME).

Purpose of the Study:

  • To review the components of the RCC TME.
  • To discuss the TME's role in disease progression and treatment resistance.
  • To explore strategies for modulating the TME to enhance therapeutic outcomes.

Main Methods:

  • Literature review of preclinical and clinical findings.
  • Analysis of TME components and their impact on therapy.
  • Discussion of combined therapeutic strategies and novel targets.

Main Results:

  • The RCC TME is dynamic, adaptive, and heterogeneous, contributing to resistance.
  • Modulating TME components offers potential to overcome resistance to anti-angiogenic and immunotherapies.
  • Combinational targeting, including anti-angiogenic agents and immune checkpoint inhibitors, shows promise.

Conclusions:

  • The TME plays a critical role in RCC progression and treatment response.
  • Targeting the TME is essential for overcoming resistance and improving patient outcomes.
  • Further research into novel TME-targeting strategies is warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
924
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
194